314 related articles for article (PubMed ID: 25581938)
21. [Association of radiotherapy and chemotherapy-targeted therapies in glioblastomas].
Laigle-Donadey F; Dehais C; Mazeron JJ; Sanson M
Bull Cancer; 2009 Mar; 96(3):291-7. PubMed ID: 19318307
[TBL] [Abstract][Full Text] [Related]
22. ASCO 2013: bevacizumab and glioblastoma--a marriage dissolution?
Addeo R; Perri F; Parlato C; Della Vittoria G
Curr Med Res Opin; 2014 Sep; 30(9):1871-3. PubMed ID: 24803042
[TBL] [Abstract][Full Text] [Related]
23. Monitoring therapeutic monoclonal antibodies in brain tumor.
Ait-Belkacem R; Berenguer C; Villard C; Ouafik L; Figarella-Branger D; Beck A; Chinot O; Lafitte D
MAbs; 2014; 6(6):1385-93. PubMed ID: 25484065
[TBL] [Abstract][Full Text] [Related]
24. Fluorescence-guided operation in recurrent glioblastoma multiforme treated with bevacizumab-fluorescence of the noncontrast enhancing tumor tissue?
Wachter D; Kallenberg K; Wrede A; Schulz-Schaeffer W; Behm T; Rohde V
J Neurol Surg A Cent Eur Neurosurg; 2012 Nov; 73(6):401-6. PubMed ID: 22777926
[TBL] [Abstract][Full Text] [Related]
25. β1 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastoma.
Carbonell WS; DeLay M; Jahangiri A; Park CC; Aghi MK
Cancer Res; 2013 May; 73(10):3145-54. PubMed ID: 23644530
[TBL] [Abstract][Full Text] [Related]
26. Bevacizumab and other targeted agents in the upfront treatment of glioblastoma.
Clarke JL
Semin Radiat Oncol; 2014 Oct; 24(4):273-8. PubMed ID: 25219812
[TBL] [Abstract][Full Text] [Related]
27. Antivascular endothelial growth factor antibody for treatment of glioblastoma multiforme.
Hanson JA; Hsu FP; Jacob AT; Bota DA; Alexandru D
Perm J; 2013; 17(4):68-74. PubMed ID: 24361023
[TBL] [Abstract][Full Text] [Related]
28. MR Perfusion-derived Hemodynamic Parametric Response Mapping of Bevacizumab Efficacy in Recurrent Glioblastoma.
Kickingereder P; Radbruch A; Burth S; Wick A; Heiland S; Schlemmer HP; Wick W; Bendszus M; Bonekamp D
Radiology; 2016 May; 279(2):542-52. PubMed ID: 26579564
[TBL] [Abstract][Full Text] [Related]
29. FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme.
Cohen MH; Shen YL; Keegan P; Pazdur R
Oncologist; 2009 Nov; 14(11):1131-8. PubMed ID: 19897538
[TBL] [Abstract][Full Text] [Related]
30. Questions regarding the optimal use of bevacizumab in glioblastoma: a moving target.
Stupp R; Weller M
Neuro Oncol; 2014 Jun; 16(6):765-7. PubMed ID: 24826844
[No Abstract] [Full Text] [Related]
31. Potential novel role of bevacizumab in glioblastoma and cervical cancer.
Goey AK; Figg WD
Cancer Biol Ther; 2014 Oct; 15(10):1296-8. PubMed ID: 25046485
[TBL] [Abstract][Full Text] [Related]
32. Bevacizumab in glioblastoma--still much to learn.
Fine HA
N Engl J Med; 2014 Feb; 370(8):764-5. PubMed ID: 24552324
[No Abstract] [Full Text] [Related]
33. Bevacizumab for newly diagnosed glioblastoma.
Chinot OL; Wick W; Cloughesy T
N Engl J Med; 2014 May; 370(21):2049. PubMed ID: 24860870
[No Abstract] [Full Text] [Related]
34. Bevacizumab for newly diagnosed glioblastoma.
Haines IE; Gabor Miklos GL
N Engl J Med; 2014 May; 370(21):2048. PubMed ID: 24849089
[No Abstract] [Full Text] [Related]
35. Treatment of glioblastoma with bevacizumab: has a new standard therapy been defined?
Chamberlain MC
CNS Drugs; 2011 Oct; 25(10):815-8. PubMed ID: 21936584
[No Abstract] [Full Text] [Related]
36. Antiangiogenic Therapy of High-Grade Gliomas.
Jo J; Wen PY
Prog Neurol Surg; 2018; 31():180-199. PubMed ID: 29393186
[TBL] [Abstract][Full Text] [Related]
37. Bevacizumab in recurrent glioblastoma: five informative patient scenarios.
Mason WP
Can J Neurol Sci; 2015 May; 42(3):149-56. PubMed ID: 25850429
[TBL] [Abstract][Full Text] [Related]
38. Bevacizumab therapy for glioblastoma: a passionate discussion.
Desjardins A; Friedman HS
CNS Oncol; 2014 Jan; 3(1):1-3. PubMed ID: 25054891
[No Abstract] [Full Text] [Related]
39. Bevacizumab as first-line therapy for glioblastoma.
Piccioni D; Lai A; Nghiemphu P; Cloughesy T
Future Oncol; 2012 Aug; 8(8):929-38. PubMed ID: 22894667
[TBL] [Abstract][Full Text] [Related]
40. Bevacizumab for newly diagnosed glioblastoma.
Gilbert MR; Sulman EP; Mehta MP
N Engl J Med; 2014 May; 370(21):2048-9. PubMed ID: 24849088
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
